QCI Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $321K | Buy |
2,980
+213
| +8% | +$24.3K | 0.02% | 122 |
|
|
2021
Q2 | $312K | Sell |
2,767
-595
| -18% | -$67K | 0.02% | 120 |
|
|
2021
Q1 | $364K | Buy |
3,362
+424
| +14% | +$45.4K | 0.02% | 115 |
|
|
2020
Q4 | $315K | Buy |
2,938
+136
| +5% | +$13.1K | 0.02% | 118 |
|
|
2020
Q3 | $245K | Buy |
2,802
+70
| +3% | +$6.59K | 0.02% | 109 |
|
|
2020
Q2 | $268K | Sell |
2,732
-67
| -2% | -$5.9K | 0.02% | 103 |
|
|
2020
Q1 | $213K | Sell |
2,799
-30
| -1% | -$2.56K | 0.02% | 115 |
|
|
2019
Q4 | $250K | Sell |
2,829
-863
| -23% | -$71.6K | 0.02% | 119 |
|
|
2019
Q3 | $280K | Sell |
3,692
-147
| -4% | -$10.1K | 0.03% | 113 |
|
|
2019
Q2 | $279K | Sell |
3,839
-78
| -2% | -$6.13K | 0.03% | 116 |
|
|
2019
Q1 | $316K | Buy |
3,917
+103
| +3% | +$8.43K | 0.03% | 102 |
|
|
2018
Q4 | $352K | Hold |
3,814
| – | – | 0.04% | 90 |
|
|
2018
Q3 | $361K | Sell |
3,814
-1,460
| -28% | -$138K | 0.03% | 103 |
|
|
2018
Q2 | $489K | Sell |
5,274
-5,871
| -53% | -$573K | 0.05% | 87 |
|
|
2018
Q1 | $1.05M | Sell |
11,145
-171,398
| -94% | -$18.8M | 0.11% | 77 |
|
|
2017
Q4 | $17.7M | Sell |
182,543
-4,771
| -3% | -$450K | 1.81% | 14 |
|
|
2017
Q3 | $16.6M | Sell |
187,314
-4,571
| -2% | -$348K | 1.85% | 14 |
|
|
2017
Q2 | $13.9M | Buy |
191,885
+3,673
| +2% | +$247K | 1.68% | 27 |
|
|
2017
Q1 | $12.3M | Buy |
188,212
+3,878
| +2% | +$244K | 1.55% | 40 |
|
|
2016
Q4 | $11.5M | Buy |
184,334
+2,798
| +2% | +$171K | 1.54% | 36 |
|
|
2016
Q3 | $11.4M | Buy |
181,536
+1,620
| +0.9% | +$105K | 1.6% | 39 |
|
|
2016
Q2 | $11.1M | Buy |
179,916
+3,537
| +2% | +$216K | 1.57% | 38 |
|
|
2016
Q1 | $10.1M | Buy |
176,379
+9,360
| +6% | +$522K | 1.48% | 44 |
|
|
2015
Q4 | $9.89M | Buy |
167,019
+7,872
| +5% | +$453K | 1.53% | 38 |
|
|
2015
Q3 | $8.66M | Buy |
159,147
+5,263
| +3% | +$343K | 1.42% | 45 |
|
|
2015
Q2 | $10.3M | Buy |
153,884
+4,381
| +3% | +$286K | 1.61% | 34 |
|
|
2015
Q1 | $8.75M | Buy |
149,503
+1,531
| +1% | +$92.5K | 1.37% | 44 |
|
|
2014
Q4 | $9.68M | Sell |
147,972
-1,079
| -0.7% | -$68K | 1.5% | 39 |
|
|
2014
Q3 | $8.61M | Buy |
149,051
+2,521
| +2% | +$140K | 1.35% | 43 |
|
|
2014
Q2 | $8.27M | Sell |
146,530
-193
| -0.1% | -$10.1K | 1.29% | 46 |
|
|
2014
Q1 | $7.54M | Sell |
146,723
-810
| -0.5% | -$40.9K | 1.22% | 49 |
|
|
2013
Q4 | $7.79M | Sell |
147,533
-12
| -0% | -$590 | 1.28% | 44 |
|
|
2013
Q3 | $6.6M | Buy |
147,545
+584
| +0.4% | +$25.9K | 1.19% | 47 |
|
|
2013
Q2 | $6.08M | Buy |
+146,961
| New | +$6.43M | 1.14% | 49 |
|
Other funds holding ABBV
QCI Asset Management's ABBV Position: Q3 2021 in Review
QCI Asset Management increased its AbbVie (ABBV) stake by 7.7% in Q3 2021, buying an estimated $24.3K and bringing the position to 2,980 shares worth $321K. The position accounts for 0.02% of the portfolio, ranked #122.
QCI Asset Management first reported a position in ABBV in Q2 2013 and has held it in 34 quarters since. The position peaked at $17.7M in Q4 2017. 2,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.
- QCI Asset Management held 2,980 shares of AbbVie worth $321K as of Q3 2021.
- QCI Asset Management bought 213 AbbVie shares in Q3 2021, an estimated $24.3K.
- AbbVie made up 0.02% of QCI Asset Management's portfolio in Q3 2021, its #122 holding.
- QCI Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 34 quarters since.
- QCI Asset Management's AbbVie position peaked at $17.7M in Q4 2017.
- 2,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.
Based on QCI Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.